A receptor that might block itself
Crossref DOI link: https://doi.org/10.1038/nature21907
Published Online: 2017-04-05
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tate, Christopher G.
Text and Data Mining valid from 2017-04-01
Article History
First Online: 5 April 2017
Competing interests
: C.G.T. is a consultant and shareholder in Heptares Therapeutics.